BioMed Alliance Spring Meeting 2026

The BioMed Alliance held its 2026 Online Spring Meeting on 15-16 June, bringing together healthcare professionals, researchers, and medical societies to discuss key developments in EU health and research policy, the future of European life sciences and innovation, and internal BioMed Alliance matters.

The meeting opened with an update on ongoing BioMed Alliance work in EU health and research policy, highlighting key legislative initiatives such as the next Multiannual Financial Framework (MFF), the proposed Biotech Act, and revisions to the Medical Devices Regulation, In Vitro Diagnostics Regulation, and the Digital Framework (Digital Omnibus). This was followed by a panel discussion with the Chairs of the different task forces, providing an opportunity to exchange views on how to strengthen our voice at EU level on these topics. The day also included governance updates, such as approval of the 2025 accounts, discussions on the budget, and the announcement of an open Board position.

The second day focused on Europe’s competitiveness in life sciences. Discussions addressed the EU’s ambition to become the world’s leading life sciences hub, alongside structural challenges in funding and implementation. The session brought together perspectives from EU institutions and stakeholders, including the European Commission, EFPIA, the ERC Scientific Council, and MedTech Europe, and highlighted Nordic experiences from Norway, Sweden, and Denmark in strengthening innovation ecosystems in translational research. Speakers emphasised the importance of integrated ecosystems, strong collaboration between academia, healthcare, and industry, and effective data governance to accelerate the translation of research into practice.

You can find the agenda below for more detailed information on the program and speakers. We will continue these discussions at our General Assembly on 1-2 December in our offices in Brussels.